Agiliti, Inc. (NYSE:AGTI) Receives Average Recommendation of “Buy” from Brokerages

Shares of Agiliti, Inc. (NYSE:AGTIGet Rating) have been given an average recommendation of “Buy” by the eleven research firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and nine have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $23.00.

Several equities research analysts have recently commented on AGTI shares. Morgan Stanley dropped their target price on shares of Agiliti from $30.00 to $24.00 and set an “overweight” rating for the company in a research report on Thursday, March 10th. BMO Capital Markets lifted their price target on shares of Agiliti from $22.00 to $28.00 and gave the company an “outperform” rating in a research report on Wednesday, April 6th. Citigroup lowered their price target on shares of Agiliti from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Wednesday, March 9th. Zacks Investment Research cut shares of Agiliti from a “hold” rating to a “sell” rating in a research report on Tuesday, March 15th. Finally, The Goldman Sachs Group lowered their price target on shares of Agiliti from $32.00 to $28.00 and set a “buy” rating for the company in a research report on Friday, March 11th.

Shares of NYSE:AGTI traded up $0.13 on Tuesday, hitting $20.49. The company had a trading volume of 547 shares, compared to its average volume of 114,721. The firm’s 50-day simple moving average is $19.85 and its two-hundred day simple moving average is $20.61. Agiliti has a 1 year low of $13.56 and a 1 year high of $26.36. The company has a quick ratio of 1.45, a current ratio of 1.72 and a debt-to-equity ratio of 1.31. The firm has a market capitalization of $2.69 billion and a price-to-earnings ratio of 107.37.

Agiliti (NYSE:AGTIGet Rating) last posted its earnings results on Tuesday, March 8th. The company reported $0.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.04. Agiliti had a net margin of 2.31% and a return on equity of 15.02%. The firm had revenue of $290.48 million during the quarter, compared to analysts’ expectations of $268.54 million. Equities research analysts anticipate that Agiliti will post 0.85 EPS for the current year.

In other news, CFO James B. Pekarek sold 15,000 shares of Agiliti stock in a transaction that occurred on Monday, February 7th. The shares were sold at an average price of $17.56, for a total value of $263,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO James B. Pekarek sold 20,000 shares of Agiliti stock in a transaction that occurred on Monday, March 14th. The stock was sold at an average price of $16.79, for a total transaction of $335,800.00. The disclosure for this sale can be found here. Insiders sold 167,289 shares of company stock valued at $3,085,284 over the last ninety days. Corporate insiders own 4.16% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. First Quadrant LLC CA bought a new stake in Agiliti during the first quarter valued at approximately $38,000. Royal Bank of Canada bought a new position in shares of Agiliti in the second quarter worth approximately $47,000. Citigroup Inc. boosted its position in shares of Agiliti by 141.0% in the fourth quarter. Citigroup Inc. now owns 6,621 shares of the company’s stock worth $153,000 after purchasing an additional 3,874 shares during the period. Morgan Stanley bought a new position in shares of Agiliti in the second quarter worth approximately $156,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Agiliti in the fourth quarter worth approximately $160,000. Institutional investors own 99.27% of the company’s stock.

Agiliti Company Profile (Get Rating)

Agiliti, Inc provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity.

See Also

Analyst Recommendations for Agiliti (NYSE:AGTI)

Receive News & Ratings for Agiliti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agiliti and related companies with MarketBeat.com's FREE daily email newsletter.